"If this 'guinea pig' culture spreads, we risk a public health crisis of 'mystery' chronic conditions caused by these unregulated peptides that the traditional medical system isn't yet equipped to reverse." At the same time as millions of posts about peptides pop up across socials, a growing number of clinics are offering peptide therapy
Description Description Oral glutathione (GSH) is notoriously vulnerable to destruction in the digestive system before reaching the cells
This asset is highly complementary to our Phase 3 FSGS program and broadens our development footprint across the kidney disease continuum, from acute injury through to chronic disease." Dr Nina Webster, CEO & Managing Director, Dimerix Limited #Dimerix #KidneyDisease #RareDisease #Biopharma #DrugDevelopment #ClinicalTrials #Nephrology #PrecisionMedicine #HealthcareInnovation #Biotech To view or add a comment, sign in ICYMI: Early phase 1 data from Bambusa Therapeutics suggests #BBT001 delivered rapid, durable improvements in atopic dermatitis severity and itch, with sustained biomarker suppression, favorable safety, and the potential for dosing as infrequently as every 3 months
Certain medical conditions and situations require caution or complete avoidance
Hypertension Energy (Not Available Currently) IV Drip Therapy Key Ingredients: 1
Other medications Because regulating hormone levels in the body is so important, some common drugs cant be taken with thyroid medication